【摘要】：目的 觀察評(píng)價(jià)聯(lián)合應(yīng)用rhGM-CSF(重組人粒細(xì)胞巨噬細(xì)胞刺激因子)凝膠與藻酸鹽敷料治療中老年體表慢性難愈性創(chuàng)面的臨床療效及安全性,探討其有關(guān)作用機(jī)制,評(píng)估將其作為一種治療中老年體表慢性難愈性創(chuàng)面的非手術(shù)療法的臨床可行性。 方法 采用非盲法隨機(jī)對(duì)照設(shè)計(jì),選擇于2011-05至2013-05在山東大學(xué)附屬濟(jì)南市中心醫(yī)院燒傷科住院治療的中老年體表慢性難愈性創(chuàng)面患者60例,采用分層隨機(jī)分組的方法將其分為4組,每組各15例。分組如下：rhGM-CSF凝膠+藻酸鹽敷料+凡士林紗布治療組(A組)；rhGM-CSF凝膠+凡士林紗布治療組(B組)；藻酸鹽敷料+凡士林紗布治療組(C組)；凡士林紗布常規(guī)治療組(D組)。試驗(yàn)周期設(shè)為8周。觀察記錄各組用藥后的不良反應(yīng)發(fā)生情況,評(píng)估治療前、治療后1,2,3,4,5,6,7,8周各時(shí)相點(diǎn)的創(chuàng)面滲液量、創(chuàng)面色澤及肉芽組織和上皮生長(zhǎng)情況、創(chuàng)面疼痛程度、創(chuàng)面愈合率,以及治療后8周各組的創(chuàng)面痊愈率、有效率。 結(jié)果 1.創(chuàng)面滲液量：入組治療前各組創(chuàng)面滲液量比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)；開(kāi)始治療后,各組創(chuàng)面滲液量均呈減少的趨勢(shì),各時(shí)相點(diǎn)組間創(chuàng)面滲液量比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)；治療后1-4周,A組和C組創(chuàng)面滲液量均少于B組和D組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；治療后5-8周,A組、B組和C組創(chuàng)面滲液量均少于D組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。 2.大體觀察：入組治療前各組創(chuàng)面色澤及肉芽組織和上皮生長(zhǎng)情況比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)；開(kāi)始治療后,各組創(chuàng)面基底均呈現(xiàn)出由黃白色蒼老肉芽向鮮紅色新鮮肉芽轉(zhuǎn)變的趨勢(shì),治療后3-8周,各組間創(chuàng)面色澤及肉芽組織和上皮生長(zhǎng)情況比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)；治療后3-4周,A組和B組在創(chuàng)面色澤、肉芽組織和上皮生長(zhǎng)情況方面均好于C組和D組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；治療后5-8周,A組、B組和C組在創(chuàng)面色澤、肉芽組織和上皮生長(zhǎng)情況方面均好于D組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。 3.創(chuàng)面疼痛程度：入組治療前各組間創(chuàng)面疼痛程度比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)；開(kāi)始治療后,各組創(chuàng)面疼痛程度總體呈現(xiàn)逐漸降低的趨勢(shì),各時(shí)相點(diǎn)組間疼痛程度比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)；治療后1-4周,A組和C組創(chuàng)面疼痛程度均低于B組和D組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；在治療后5-8周,A組、B組和C組創(chuàng)面疼痛程度均低于D組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。 4.創(chuàng)面愈合率：治療后1周,各組間創(chuàng)面愈合率比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)；治療后2周-8周,各組間創(chuàng)面愈合率比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)；A組、B組和C組的創(chuàng)面愈合率均高于D組,其中A組創(chuàng)面愈合率最高,其后依次為B組,C組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。 5.治療后8周各組的創(chuàng)面痊愈率及有效率：治療后8周,各組間創(chuàng)面痊愈率及有效率比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)；A組、B組和C組的創(chuàng)面痊愈率及有效率均高于D組,其中A組創(chuàng)面痊愈率及有效率高于B組和C組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。 6.不良反應(yīng)：試驗(yàn)過(guò)程中各組均未見(jiàn)明顯不良反應(yīng)。 結(jié)論 rhGM-CSF聯(lián)合藻酸鹽敷料治療中老年體表慢性難愈性創(chuàng)面有協(xié)同互補(bǔ)作用,不僅能刺激肉芽組織增生,加速再上皮化,促進(jìn)創(chuàng)面愈合；還能明顯減少創(chuàng)面滲液量,減輕換藥時(shí)創(chuàng)面疼痛,提高了患者治療依從性和日常生活護(hù)理質(zhì)量；且未發(fā)現(xiàn)明顯不良反應(yīng)。將其作為一種治療中老年體表慢性難愈性創(chuàng)面的的非手術(shù)療法既安全又有效,具有臨床可行性。
[Abstract]:Purpose To evaluate the clinical efficacy and safety of rhGM-CSF (recombinant human granulocyte-macrophage stimulating factor) gel and alginate dressing in the treatment of chronic refractory wound in the middle-aged and the elderly, and to explore its related effects Mechanism and evaluation as a non-operative treatment for the treatment of chronic refractory wound on the surface of the middle-aged and the elderly line property Methods The non-blind randomized controlled design was used to select 60 cases of chronic refractory wound in the middle-aged and old-aged and middle-aged and middle-aged and old-aged patients who were hospitalized in the Central Hospital of Jinan, Shandong University, from 2011 to 05 to 2013-05. The method of stratified random grouping was divided into 4 groups. Group, 15 in each group. The group was as follows: rhGM-CSF gel + alginate dressing + Vaseline gauze treatment group (group A); rhGM-CSF gel + Vaseline gauze treatment group (group B); alginate dressing + Vaseline gauze treatment group (group C); Vaseline gauze often Gauge treatment group (group D). The test period was set to 8 weeks. The occurrence of the adverse reaction after the treatment was recorded. The amount of the wound exudate, the color of the wound, the tissue of the wound and the growth of the epithelium, the degree of wound pain, the rate of wound healing, and the 8-week post-treatment were evaluated before and after the treatment. the creation of each group face-to-face Results 1. The recovery rate and the effective rate. Results 1. The amount of the wound exudate in each group was not statistically significant (P0.05). After the treatment, the amount of the wound exudate in each group was decreased, and the difference of the amount of wound exudate between the groups at the time of treatment was statistically significant (P <0.05). There was no difference between group A and group D in group A and group C after treatment for 1-4 weeks after treatment (P <0.05), and the amount of wound liquid in group A, group B and group C was less than that of group D and poor in group A, group B and group C. There was no significant difference in the difference between the color of the wound and the tissue of the granulation and the growth of the epithelium (P0.05). There was a significant difference in the color of the wound, the tissue of the wound and the growth of the epithelium in the 3-8 weeks after the treatment (P0.05). The difference was statistically significant between the group C and the D group in the group A and group B after 3-4 weeks of treatment. significance (P0.05); 5-8 weeks after treatment, group A, group B and group C were good in the color of the wound, the tissue of granulation and the growth of the epithelium. There was no significant difference in the degree of wound pain in the group (P0.05). The degree of pain in group A, group B and group C was significantly lower than that in group B and D (P0.05). The degree of pain in group A, group B and group C were all lower than that of group B and group D after 1-4 weeks after treatment (P0.05). There was no significant difference in the rate of wound healing in group D (P0.05). 4. The rate of wound healing was not significant (P0.05). The rate of wound healing in group A, group B and group C was higher than that of group D, and the rate of wound healing in group A was the highest. In group B and group C, the difference was significant (P0.05). The recovery rate and the effective rate of the wound in each group at 8 weeks after treatment were statistically significant (P0.05). 5) The recovery rate and effective rate of wound surface in group A, group B and group C were higher than that of group D. The effective rate was higher than that of group B and group C (P0.05). 5). 6. Adverse reaction: no obvious adverse reaction was found in each group during the test. Conclusion The combination of rhGM-CSF and alginate dressing in the treatment of chronic refractory wound surface in the middle-aged and the elderly has a synergistic effect, not only can stimulate the proliferation of granulation tissue, accelerating and re-epithelialization, and promoting wound healing; and also can obviously reduce the amount of the wound exudate and reduce the drug change, The wound pain is improved, the patient's treatment compliance and daily life care quality are improved, and no obvious adverse reaction is found.
【學(xué)位授予單位】：山東大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R644

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 唐漢鈞,陳紅風(fēng),程亦勤,劉曉鶇,闕華發(fā),向寰宇,鄭勇,邢捷,沈亮,陳莉穎,單瑋;合并綠膿桿菌感染的難愈性創(chuàng)面的中醫(yī)藥治療——附72例臨床資料分析[J];上海中醫(yī)藥雜志;2004年04期

2 劉麗軍,張吉?jiǎng)?楊玉嵐;氯霉素在26例痔術(shù)后難愈性創(chuàng)面中的應(yīng)用[J];中國(guó)民康醫(yī)學(xué);2004年03期

3 唐雨發(fā);60例嚴(yán)重創(chuàng)傷難愈性創(chuàng)面的治療分析[J];醫(yī)學(xué)文選;2004年06期

4 ;皮膚組織工程與難愈性創(chuàng)面治療新進(jìn)展學(xué)習(xí)班通知[J];中華損傷與修復(fù)雜志(電子版);2011年01期

5 高愛(ài)鳳;“多濟(jì)敷”治療難愈性創(chuàng)面32例療效觀察[J];天津護(hù)理;2005年02期

6 潘翠環(huán),張慈風(fēng);綜合物理治療與康惠爾系列對(duì)難愈性創(chuàng)面的臨床觀察[J];廣州醫(yī)學(xué)院學(xué)報(bào);2002年04期

7 沈蓉蓉;毛雅芬;陳靜娟;;霧化云南白藥液聯(lián)合局部氧氣治療難愈性創(chuàng)面的效果[J];上海護(hù)理;2008年06期

8 靳志鵬;孔德鴻;屠勝哲;;慶大霉素和山莨菪堿外用治療難愈性創(chuàng)面44例[J];航空軍醫(yī);2005年04期

9 孫冬寧;;綜合物理治療與現(xiàn)代傷口敷料系列對(duì)老年人難愈性創(chuàng)面的臨床觀察[J];實(shí)用醫(yī)技雜志;2007年02期

10 華樹(shù)良;韋文;;負(fù)壓封閉引流修復(fù)難愈性創(chuàng)面的研究進(jìn)展[J];右江醫(yī)學(xué);2010年06期

相關(guān)會(huì)議論文 前10條

1 薛寶升;;難愈性創(chuàng)面治療總結(jié)[A];中華醫(yī)學(xué)會(huì)燒傷外科學(xué)分會(huì)2009年學(xué)術(shù)年會(huì)論文匯編[C];2009年

2 張鮮英;劉毅;張緒生;張斌;張誠(chéng);李玉環(huán);楊雪麗;;難愈性創(chuàng)面的外科治療[A];中華醫(yī)學(xué)會(huì)燒傷外科學(xué)分會(huì)2009年學(xué)術(shù)年會(huì)論文匯編[C];2009年

3 李玉環(huán);劉毅;張鮮英;;自制簡(jiǎn)易創(chuàng)面封閉負(fù)壓治療技術(shù)處理難愈性創(chuàng)面的護(hù)理[A];中華醫(yī)學(xué)會(huì)燒傷外科學(xué)分會(huì)2009年學(xué)術(shù)年會(huì)論文匯編[C];2009年

4 闕華發(fā);張臻;邢捷;徐杰男;沈亮;王云飛;朱元穎;單瑋;;中醫(yī)藥促進(jìn)慢性難愈性創(chuàng)面愈合的機(jī)制研究[A];中華中醫(yī)藥學(xué)會(huì)周圍血管病分會(huì)2010年學(xué)術(shù)大會(huì)論文集[C];2010年

5 張斌;劉毅;齊向東;李勤;;臀部及下肢難愈性創(chuàng)面的整形外科綜合治療[A];第七屆中國(guó)醫(yī)師協(xié)會(huì)美容與整形醫(yī)師大會(huì)論文集[C];2010年

6 張斌;劉毅;李勤;齊向東;;臀部及下肢難愈性創(chuàng)面的整形外科綜合治療[A];中華醫(yī)學(xué)會(huì)整形外科學(xué)分會(huì)第十一次全國(guó)會(huì)議、中國(guó)人民解放軍整形外科學(xué)專業(yè)委員會(huì)學(xué)術(shù)交流會(huì)、中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)醫(yī)學(xué)美容專業(yè)委員會(huì)全國(guó)會(huì)議論文集[C];2011年

7 張斌;劉毅;李勤;齊向東;;臀部及下肢難愈性創(chuàng)面的整形外科綜合治療[A];中華醫(yī)學(xué)會(huì)整形外科學(xué)分會(huì)第十一次全國(guó)會(huì)議、中國(guó)人民解放軍整形外科學(xué)專業(yè)委員會(huì)學(xué)術(shù)交流會(huì)、中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)醫(yī)學(xué)美容專業(yè)委員會(huì)全國(guó)會(huì)議論文集[C];2011年

8 祁強(qiáng);林偉;李永林;肖海濤;楊青;崔浩杰;;骶尾部脊索瘤術(shù)后難愈性創(chuàng)面的臨床分析[A];第七屆全國(guó)創(chuàng)傷學(xué)術(shù)會(huì)議暨2009海峽兩岸創(chuàng)傷醫(yī)學(xué)論壇論文匯編[C];2009年

9 陳欣;王曉軍;王成;陳輝;張國(guó)安;;應(yīng)用人工真皮和自體皮膚移植修復(fù)難愈性創(chuàng)面[A];中華醫(yī)學(xué)會(huì)燒傷外科學(xué)分會(huì)2009年學(xué)術(shù)年會(huì)論文匯編[C];2009年

10 夏成德;張業(yè)龍;薛繼東;李曉亮;狄海萍;牛希華;李強(qiáng);;臀部難愈性創(chuàng)面治療體會(huì)[A];急慢性創(chuàng)面治療新技術(shù)專題系列研討會(huì)之感染創(chuàng)面綜合治療論壇論文匯編[C];2011年

相關(guān)重要報(bào)紙文章 前3條

1 南京軍區(qū)福州總醫(yī)院附屬第一醫(yī)院燒傷整形科主任 詹新華 整理 吳志 葛建偉;負(fù)壓封閉吸引術(shù)促傷口愈合[N];健康報(bào);2009年

2 本報(bào)記者 謝慧　同濟(jì)大學(xué)經(jīng)濟(jì)與管理學(xué)院教授 陳松;開(kāi)拓醫(yī)用生物敷料產(chǎn)業(yè)新領(lǐng)域[N];經(jīng)濟(jì)日?qǐng)?bào);2009年

3 北京中醫(yī)藥大學(xué)東方醫(yī)院 代紅雨　張燕生 張董曉;中醫(yī)瘡瘍專業(yè)亟須拯救[N];健康報(bào);2010年

相關(guān)碩士學(xué)位論文 前10條

1 李龍;小牛血去蛋白提取物治療難愈性創(chuàng)面的臨床研究[D];山東大學(xué);2012年

2 高棟梁;濕潤(rùn)環(huán)境治療難愈性創(chuàng)面的臨床研究[D];延安大學(xué);2013年

3 楊華蓮;人工真皮聯(lián)合自體薄層皮片移植修復(fù)難愈性創(chuàng)面的臨床研究[D];廣西醫(yī)科大學(xué);2014年

4 王順梅;表柔比星復(fù)合皮膚缺損建立大鼠氧化應(yīng)激難愈性創(chuàng)面模型的研究[D];北京中醫(yī)藥大學(xué);2012年

5 唐林平;脂肪來(lái)源血管基質(zhì)成分（SVF）在難愈性創(chuàng)面愈合中的作用[D];南京大學(xué);2013年

6 李禮;貫穿縫扎聯(lián)合打孔法構(gòu)建兔耳難愈性創(chuàng)面模型[D];廣西醫(yī)科大學(xué);2012年

7 岳立明;rhGM-CSF聯(lián)合藻酸鹽敷料治療中老年體表慢性難愈性創(chuàng)面的臨床觀察[D];山東大學(xué);2014年

8 張?jiān)?小劑量胰島素和Hsp90α在糖尿病難愈性創(chuàng)面中的作用[D];第四軍醫(yī)大學(xué);2013年

9 林忠泵;封閉負(fù)壓治療慢性難愈性創(chuàng)面的應(yīng)用體會(huì)[D];浙江大學(xué);2009年

10 劉志君;VEGF165轉(zhuǎn)染真皮多能干細(xì)胞及其對(duì)放創(chuàng)復(fù)合難愈性創(chuàng)面促愈的實(shí)驗(yàn)研究[D];第三軍醫(yī)大學(xué);2004年

，

本文編號(hào)：2343657